ARTA
KURA icon

A.R.T. Advisors’s Kura Oncology KURA Stock Holding History

A.R.T. Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,257
Closed -$402K – 552
2019
Q4 		$402K Buy
+29,257
New +$434K 0.02% 930
2019
Q3 		– Sell
-22,989
Closed -$453K – 1580
2019
Q2 		$453K Buy
+22,989
New +$382K 0.03% 782

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's KURA Position: Q1 2020 in Review

A.R.T. Advisors sold out of Kura Oncology (KURA) in Q1 2020, closing a stake of 29,257 shares — an estimated $402K sold.

A.R.T. Advisors first reported a position in KURA in Q2 2019 and held it in 2 quarters. The position peaked at $453K in Q2 2019. 119 funds tracked by Wall St. Rank hold KURA as of Q1 2020.

  • A.R.T. Advisors reported no remaining Kura Oncology position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 29,257 Kura Oncology shares in Q1 2020, an estimated $402K.
  • A.R.T. Advisors first reported a position in Kura Oncology in Q2 2019 and held it in 2 quarters.
  • A.R.T. Advisors's Kura Oncology position peaked at $453K in Q2 2019.
  • 119 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.